SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 179.06 |
| Enterprise Value ($M) | 139.75 |
| Book Value ($M) | 65.56 |
| Book Value / Share | 0.73 |
| Price / Book | 2.73 |
| NCAV ($M) | 58.80 |
| NCAV / Share | 0.66 |
| Price / NCAV | 3.05 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.28 |
| Return on Assets (ROA) | -0.22 |
| Return on Equity (ROE) | -0.27 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 4.36 |
| Current Ratio | 4.36 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 114.58 |
| Assets | 121.33 |
| Liabilities | 55.77 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 33.46 |
| Operating Income | -12.99 |
| Net Income | -18.75 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -35.89 |
| Cash from Investing | 35.51 |
| Cash from Financing | 3.08 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 44,556 | 269,496 | 16.53 | |
| 23,859 | 103,209 | 23.12 | |
| 20,621 | 48,620 | 42.41 | |
| 71,644 | 74,502 | 96.16 | |
| 20,835 | 44,896 | 46.41 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| CELU – Celularity Inc. | CELZ – Creative Medical Technology Holdings, Inc. |
| CERE – Cerevel Therapeutics Holdings, Inc. | CING – Cingulate Inc. |
| CKPT – Checkpoint Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io